Merck, 700120P-1MG, 7α,24(R/S)-dihydroxycholestenone-d7

Name: 7α,24(R/S)-dihydroxycholestenone-d7
Brand: Merck
SKU: 700120P-1MG

Size:1 mg, 111114, 7α, 24(R/S)-dihydroxycholestenone-d7, powder

Catalog Number: 700120P-1MG

Pricing

Send an RFQ.

View RFQ List

Category

Dry Ice

Pack Size1 mg

TagsChemistry & Biochemicals Biochemicals Avanti Research™A Croda Brand

CollectionsMerck Biochemicals Collection: Trusted Lab Reagents & Buffers Merck Cell Culture Supplements & Reagents: Complete Solutions for Research & Bioproduction Merck Roche Life Science Products for PCR, RT‑PCR & Nucleic Acid Purification

Description

General description
7α,24(R/S)-dihydroxycholestenone-d7 is a deuterated derivative of the oxysterol 7α,24(R/S)-dihydroxycholestenone. 7α,24-dihydroxy-3-oxocholest-4-en-26-oic acid is synthesized from 3β,7α,24 S-trihydroxycholest-5-en-(25 R)26-oic acid ((25 R)CA5-3β,7α,24 S-triol) in the presence of enzyme 3β-hydroxysteroid dehydrogenase type 7 (HSD3B7). 7α,24(S)-dihydroxycholestenone is also derived by the 7α-hydroxylation of 24S hydroxycholesterol (24S-HC) in the presence of enzyme oxysterol 7-α-hydroxylase 2 (CYP39A1).
Packaging
5 mL Amber Glass Screw Cap Vial (700120P-1mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC

Specifications

General

MDL number	MFCD22495329
Web Name Suffix Override	Avanti Research™ - A Croda Brand
NACRES	NA.25
UNSPSC Code	41141804
assay	>99% (TLC)
form	powder
packaging	pkg of 1 × 1 mg (700120P-1mg)
manufacturer/tradename	Avanti Research™ - A Croda Brand 700120P
shipped in	dry ice
storage temp.	−20°C

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.